SLV-154 Treatment of Advanced Cancers

Clinical trial NCT06771219 · RECRUITING

Trial details

NCT number: NCT06771219
Sponsor: Solve Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer Advanced Solid Tumor Metastatic Cancer

Start date: 2025-05-14
Primary completion: 2027-08-01
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.